Today

Agents

Chat

Arena

Discover

More

App

Kiniksa Pharmaceuticals names Ross Moat president and chief operating officer - KNSA News | Rallies

Kiniksa Pharmaceuticals names Ross Moat president and chief operating officer

KNSA•2026-10-22

Kiniksa Pharmaceuticals appointed Ross Moat president and chief operating officer, effective immediately on October 17, 2026.

1. Leadership appointment

Moat previously served as Kiniksa’s executive vice president and chief operating officer. He joined the company in June 2019.

Related News

Vylor declares quarterly dividend of $0.0013 per share

VYLR•2026-10-22

Labcorp partners with FDA, Charles River to advance drug abuse potential testing

CRL•2026-10-22

Nasdaq gives ARC Group Acquisition I until Feb. 23, 2027 to regain warrant listing compliance

Sources

S

Kiniksa Pharmaceuticals names Ross Moat president and chief operating officer

Sec

ARCL

•

2026-10-22

Chime Financial co-founder Ryan A. King reports sale of $351,162.4542 in common shares

CHYM•2026-10-22

MISO selects Ameren-led consortium for $1.23 billion Iowa transmission project

AEE•2026-10-22